Cyclic lipid derivatives as potent PAF antagonists

Details Cyclic lipid derivatives as potent PAF antagonists Cyclic lipid derivatives as potent PAF antagonists

1995-11-06

1997-12-23

Fan, Jane

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514336, 514357, 5462797, 5462817, 5462681, 546309, 546175, 546335, 548204, A61K 3144, C07D40112

Patent

active

057008175

ABSTRACT:
The present invention describes novel cyclic diol derivatives represented by formula I and II: ##STR1## in which Y represents O, S, SO, SO.sub.2, (CH.sub.2).sub.m wherein m is zero or an integer of 1 to 5, or NR.sup.2 group wherein R.sup.a is hydrogen, lower alkyl, lower alkoxycarbonyl, aryl, arylalkyl or acyl;

REFERENCES:
patent: 4665197 (1987-05-01), de Nie-Sarink et al.
patent: 4701534 (1987-10-01), Mason et al.
patent: 4851450 (1989-07-01), Demopoulos
patent: 4891363 (1990-01-01), Nakamura et al.
patent: 4940706 (1990-07-01), Bartoli et al.
patent: 4945098 (1990-07-01), Grue-Sorensen et al.
patent: 4987132 (1991-01-01), Mase et al.
patent: 4997843 (1991-03-01), Carceller et al.
patent: 5004569 (1991-04-01), Meier et al.
patent: 5047420 (1991-09-01), Graham et al.
Chemical Abstracts, vol. 114, No. 19 (1991), Tsushima et al., "Preparation of pyridinium compounds as platelet-activatingfactor (PAF) antagonists", p. 769, col. 1.
Chemical Abstracts, vol. 116, No. 13 (1992), Kertscher et al., "PAF antagonistswith phospholipid structure. Part 2: Phospholipids with heteroarene head groups and increased phosphorus-nitrogendistance: synthesis, characterizationand structure-activityrelationships", p. 946, col. 2.
Chemical Abstracts, vol. 116. No. 13 (1992), Kertscher et al., "PAF antagonists with phospholipidstructure. Part 1: Phospholipids with heteroarene heteroarene head groups: synthesis, characterizationand activity-determiningstructural requirements", p. 946, Col. 2.
Chemical Abstracts, vol. 116, No. 1 (1992), Okano et al., "Preparation of cyclohexanediol derivatives as platelet-activatingfactor (PAF) antagonists", p. 613, col. 1.
Matyas Koltai et al., "Platlet Activating Factor (PAF) A Review of its Effects . . . (Part I)", Drugs 42 (1) (1991), pp. 9-29.
Matyas Koltai et al., "PAF A Review of Its Effects . . . (Part II)", Drugs 42 (2) (1991), pp. 174-204.
Michael C. Venuti, "Platelet Activating Factor Receptors", ComprehensiveMed. Chem., vol. 3 (1990) pp. 715-761.
Kelvin Cooper et al., "SAR of PAF Antagonists", Annual Reports in Medicinal Chemistry, vol. 24, Chapter 9 (1989), pp. 81-90.
CA 73: 87792 Beiezin 1970.
The Journal of Experimental Medicine, vol. 136 (1972), Jaques Benveniste et al., "Leukocyte-Dependent Histamine Release From Rabbit Platelets", pp. 1356-1377.
CA 107: 39243 Gautam et al. 1986.

Affiliated with

Also associated with

Rating

Cyclic lipid derivatives as potent PAF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic lipid derivatives as potent PAF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic lipid derivatives as potent PAF antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1803051